Ryaltris Nasal Spray

Ryaltris Nasal Spray is a combination medication used to treat symptoms of seasonal allergic rhinitis, such as a stuffy or runny nose, itching, and sneezing. It contains two active ingredients: olopatadine hydrochloride, an antihistamine that blocks histamine effects, and mometasone furoate, a corticosteroid that reduces inflammation in the nasal passages. (webmd.com)

Manufactured by Glenmark Pharmaceuticals Ltd., an Indian pharmaceutical company, Ryaltris is produced in multiple countries to meet global demand. (grandpharm.com)

In 2022, Hikma Pharmaceuticals PLC, a UK-based multinational pharmaceutical company, acquired the rights to distribute Ryaltris in the United States. (hikma.com)

Ryaltris is available in various countries, including the United States, where it is approved by the FDA for the treatment of seasonal allergic rhinitis in adults and pediatric patients aged 12 years and older. (us.ryaltris.com)

The product is generally well-tolerated, with common side effects including taste disturbances, nosebleeds, and nasal discomfort. (webmd.com)

Please consult a healthcare professional before using Ryaltris to ensure it is appropriate for your condition and to discuss potential side effects and interactions.